Nutrien (NTR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

08.05.25 03:00 Uhr

Werte in diesem Artikel
Aktien

48,02 EUR -1,64 EUR -3,30%

Indizes

PKT PKT

7.893,4 PKT -43,0 PKT -0,54%

25.161,2 PKT 186,5 PKT 0,75%

For the quarter ended March 2025, Nutrien (NTR) reported revenue of $5.1 billion, down 5.4% over the same period last year. EPS came in at $0.11, compared to $0.46 in the year-ago quarter.The reported revenue represents a surprise of -4.18% over the Zacks Consensus Estimate of $5.32 billion. With the consensus EPS estimate being $0.33, the EPS surprise was -66.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Nutrien performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Potash - Sales volumes - Total: 3,402 KTon versus the five-analyst average estimate of 3,255.3 KTon. Nitrogen - Sales volumes - Total: 2,469 KTon versus the five-analyst average estimate of 2,473.23 KTon. Average Selling Price per Tonne - Phosphate - Industrial and feed: 817 $/Ton versus the five-analyst average estimate of 777.8 $/Ton. Average Selling Price per Tonne - Phosphate - Total: 710 $/Ton versus 614.19 $/Ton estimated by five analysts on average. Sales- Retail (Nutrient Ag Solutions)- Total: $3.09 billion versus $3.49 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -6.6% change. Sales- Potash: $861 million versus the six-analyst average estimate of $783.90 million. The reported number represents a year-over-year change of -7.1%. Sales- Phosphate: $405 million versus $435.19 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -18.8% change. Sales- Nitrogen: $1.07 billion versus the six-analyst average estimate of $972.08 million. The reported number represents a year-over-year change of +4.5%. Net Sales- Eliminations: -$288 million versus -$391.41 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -9.4% change. Net Sales- Potash: $744 million versus the five-analyst average estimate of $665.54 million. The reported number represents a year-over-year change of -8.5%. Net Sales- Nitrogen: $954 million versus $848.02 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +4.7% change. Sales- Retail (Nutrient Ag Solutions)- Crop nutrients: $1.19 billion versus $1.61 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -8.8% change. View all Key Company Metrics for Nutrien here>>>Shares of Nutrien have returned +20.5% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nutrien Ltd. (NTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Nutrien (Ex Potash Agrium)

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nutrien (Ex Potash Agrium)

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Nutrien (Ex Potash Agrium)

Wer­bung

Analysen zu Nutrien (Ex Potash Agrium)

DatumRatingAnalyst
15.04.2025Nutrien (Ex Potash Agrium) BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.04.2025Nutrien (Ex Potash Agrium) BuyJefferies & Company Inc.
07.04.2025Nutrien (Ex Potash Agrium) NeutralUBS AG
03.03.2025Nutrien (Ex Potash Agrium) NeutralJP Morgan Chase & Co.
28.02.2025Nutrien (Ex Potash Agrium) BuyJefferies & Company Inc.
DatumRatingAnalyst
15.04.2025Nutrien (Ex Potash Agrium) BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.04.2025Nutrien (Ex Potash Agrium) BuyJefferies & Company Inc.
28.02.2025Nutrien (Ex Potash Agrium) BuyJefferies & Company Inc.
27.01.2025Nutrien (Ex Potash Agrium) BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.01.2025Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
DatumRatingAnalyst
07.04.2025Nutrien (Ex Potash Agrium) NeutralUBS AG
03.03.2025Nutrien (Ex Potash Agrium) NeutralJP Morgan Chase & Co.
20.02.2025Nutrien (Ex Potash Agrium) NeutralUBS AG
13.01.2025Nutrien (Ex Potash Agrium) NeutralJP Morgan Chase & Co.
07.11.2024Nutrien (Ex Potash Agrium) NeutralUBS AG
DatumRatingAnalyst
18.11.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
09.08.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
23.02.2024Nutrien (Ex Potash Agrium) UnderweightJP Morgan Chase & Co.
07.07.2023Nutrien (Ex Potash Agrium) UnderperformCredit Suisse Group
16.02.2023Nutrien (Ex Potash Agrium) UnderperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nutrien (Ex Potash Agrium) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen